News Remedy Meds buys telehealth rival in $500m marriage Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a $500m-plus deal to buy Thirty Madison.
News Gilead, Amgen kick off facility investments in US This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.
News Ametris starts obesity digital endpoint project with pharma Ametris launches a collaboration with pharma companies that aims to show how digital endpoints can be used in obesity trials.
News 'Brainwave' test raises hopes of early dementia diagnosis A three-minute test could help diagnose people at risk of developing dementia, spotting signs of cognitive decline years before other approaches.
News Uni wins big NIHR grant for healthtech 'horizon scanning' A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.
News Scoop: Lumos Labs has FDA nod for ADHD DTx Prismira Lumos Labs has secured its first 510(k) clearance for a digital therapeutics offering, paving the way for entrance into the regulated app market.
News NICE backs Roche's non-Hodgkin lymphoma drug Columvi NICE backs NHS use of Roche's Columvi as a second-line therapy for a form of non-Hodgkin lymphoma affecting thousands of people in the UK each year.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
